Stockholders' Equity (Details) - $ / shares |
12 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Equity [Abstract] | ||
Restricted stock, Outstanding Number of shares, Beginning Balance | 162,500 | 340,000 |
Restricted stock, Weighted Average Grant Date Fair Value, Beginning Balance | $ 2.25 | $ 2.15 |
Grants of restricted stock units | 45,000 | 70,000 |
Grants of restricted stock units, Weighted Average Grant Date Fair Value | $ 3.51 | $ 2.68 |
Vested restricted stock units | (195,000) | (247,500) |
Vested restricted stock units, Weighted Average Grant Date Fair Value | $ (2.47) | $ (2.23) |
Unvested Resricted stock, Outstanding Number of shares, Ending Balance | 12,500 | 162,500 |
Unvested Restricted stock, Weighted Average Grant Date Fair Value, Ending Balance | $ 3.36 | $ 2.25 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Number of options vested. No definition available.
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|